Ann: Investor Webinar, page-196

@rainbowdaisy..

What is the point of you posting here??

The only people that could possibly be interested are those that are looking in the data room, but instead of going over your claims with them, you are posting here. Why bother, we are not interested.

There are multiple parties going over the data with more to come according to the Dr. Those companies don't seem to have any issue with the quality of our spodumene concentrate, so neither do the rest of us.

Why aren't you trying to contact them?? Why are you not pulling up AVZ for making the same mistake that you perceive Firefinch is making?? (neither company is calling reserves incorrectly BTW, but you don't seem to be able to accept this). However you only call out FFX and Not AVZ for doing exactly the same thing. YOU are obviously wrong again/still.

If there were any problems with our product then the companies looking at all the data wouldn't be there at all. They are there, so move along try a different path.

You could still buy in what is obviously a still undervalued company, according to demand for shares in the only market that counts.